Cargando…

Annual reports in medicinal chemistry. Volume 23 /

ANNUAL REPORTS IN MED CHEMISTRY V23 PPR.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: American Chemical Society. Division of Medicinal Chemistry
Otros Autores: Berger, Joel G.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: San Diego : Academic Press, �1988.
Colección:Annual reports in medicinal chemistry ; v. 23
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ia 4500
001 SCIDIR_ocn300788959
003 OCoLC
005 20231117015211.0
006 m o d
007 cr cnu---unuuu
008 090131s1988 caua ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d UBY  |d IDEBK  |d E7B  |d OCLCQ  |d OPELS  |d OCLCQ  |d OCLCF  |d OCLCQ  |d DEBSZ  |d LEAUB  |d VLY  |d OCLCO  |d OCLCQ 
019 |a 505146039  |a 646758442  |a 1162091082 
020 |a 9780080583679  |q (electronic bk.) 
020 |a 0080583679  |q (electronic bk.) 
020 |a 0120405237  |q (electronic bk.) 
020 |a 9780120405237  |q (electronic bk.) 
020 |a 1281739863 
020 |a 9781281739865 
020 |a 9786611739867 
020 |a 6611739866 
035 |a (OCoLC)300788959  |z (OCoLC)505146039  |z (OCoLC)646758442  |z (OCoLC)1162091082 
050 4 |a RS402  |b .A65eb vol. 23 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
082 0 4 |a 615/.19  |2 22 
245 0 0 |a Annual reports in medicinal chemistry.  |n Volume 23 /  |c section editors, Joel G. Berger [and others]. 
260 |a San Diego :  |b Academic Press,  |c �1988. 
300 |a 1 online resource (390 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Annual reports in medicinal chemistry ;  |v v. 23 
504 |a Includes bibliographical references and indexes. 
588 0 |a Print version record. 
505 0 |a Front Cover; Annual Reports in Medicinal Chemistry, Volume 23; Copyright Page; CONTENTS; CONTRIBUTORS; PREFACE; SECTION I: CNS AGENTS; Chapter 1. Antipsychotic Agents; Chapter 2. Analgesics; Chapter 3. Antianxiety Agents and Anticonvulsants; Chapter 4. Agents for the Treatment of Cognitive Disorders; Chapter 5. Central Nervous System Actions of Adenosine Agonists and Antagonists; Chapter 6. Central Serotonin Receptors: Opportunities for Drug Discovery; SECTION II: CARDIOPULMONARY AND VASCULAR AGENTS; Chapter 7. Antihypertensive Agents; Chapter 8. Pulmonary and Antiallergy Agents 
505 8 |a Chapter 9. Peripheral Actions of Selective Muscarinic Agonists and AntagonistsChapter 10. Vasopressin Antagonists; Chapter 11. Atrial Natriuretic Peptide; Chapter 12. Plasminogen Activators; SECTION III: CHEMOTHERAPEUTIC AGENTS; Chapter 13. Beta-Lactam Antibiotics; Chapter 14. Quinolone Antibacterial Agents; Chapter 15. Novel Approaches Toward Discovery of Antibacterial Agents; Chapter 16. Chemical Modification of Antibodies for Cancer Chemotherapy; Chapter 17. Antiviral Agents; SECTION IV: ENDOCRINOLOGY, IMMUNOLOGY AND METABOLIC DISORDERS 
505 8 |a Chapter 18. Immunomodulatory Approaches to the Treatment of InflammationChapter 19. Modulation of Arachidonic Acid Metabolism in the Treatment of Rheumatoid Arthritis; Chapter 20. The Pharmacological Treatment of Obesity; Chapter 21. Gastrointestinal Motility Enhancing Agents; Chapter 22. Luteinizing Hormone Releasing Hormone Analogs In Control of Fertility and Gonadal Hormone Dependent Disease; SECTION V: TOPICS IN BIOLOGY; Chapter 23. Structure and Function of G-Protein Coupled Receptors; Chapter 24. G-proteins as Receptor-Effector Couplers; Chapter 25. Isozymes of Protein Kinase C 
505 8 |a Chapter 26. Therapeutic Strategies in the Treatment of AIDSChapter 27. Enzyme Changes Linked to Anticancer Drug Resistance; SECTION VI: TOPICS IN CHEMISTRY AND DRUG DESIGN; Chapter 28. Applications of NMR Spectroscopy to Protein Structure Determination; Chapter 29. Search Strategies for Determining Bioactive Conformers of Peptides and Small Molecules; Chapter 30. Oligonucleotide Inhibitors of Gene Expression in Living Cells: New Opportunities in Drug Design; Chapter 31. Enzyme Assisted Transformations in Organic Media 
505 8 |a Chapter 32. Mechanistic Aspects of Xenobiotic Metabolism as Related to Drug DesignSECTION VII: SPECIAL TOPICS; Chapter 33. To Market, To Market -- 1987; COMPOUND NAME, CODE NUMBER AND SUBJECT INDEX; CUMULATIVE CHAPTER TITLES KEYWORD INDEX, VOLUMES 1-23; CUMULATIVE CONTRIBUTOR INDEX, VOLUMES 1-23; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1987; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1987, BY INDICATION 
520 |a ANNUAL REPORTS IN MED CHEMISTRY V23 PPR. 
546 |a English. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Clinical chemistry. 
650 2 |a Chemistry, Pharmaceutical  |0 (DNLM)D002626 
650 2 |a Chemistry, Clinical  |0 (DNLM)D002624 
650 6 |a Chimie pharmaceutique.  |0 (CaQQLa)201-0028674 
650 6 |a Chimie clinique.  |0 (CaQQLa)201-0016714 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a Clinical chemistry.  |2 fast  |0 (OCoLC)fst00864330 
650 7 |a Pharmaceutical chemistry.  |2 fast  |0 (OCoLC)fst01060115 
700 1 |a Berger, Joel G. 
710 2 |a American Chemical Society.  |b Division of Medicinal Chemistry. 
776 0 8 |i Print version:  |t Annual reports in medicinal chemistry. Volume 23.  |d San Diego : Academic Press, �1988  |z 9780120405237 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780120405237  |z Texto completo